Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 34

1.

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.

James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D.

Lancet Oncol. 2013 May;14(6):516-24. doi: 10.1016/S1470-2045(13)70086-X. Epub 2013 Apr 9.

PMID:
23578724
2.

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.

J Clin Oncol. 2012 Dec 10;30(35):4344-51. doi: 10.1200/JCO.2012.43.8085. Epub 2012 Nov 13.

3.

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

Peiffert D, Tournier-Rangeard L, Gérard JP, Lemanski C, François E, Giovannini M, Cvitkovic F, Mirabel X, Bouché O, Luporsi E, Conroy T, Montoto-Grillot C, Mornex F, Lusinchi A, Hannoun-Lévi JM, Seitz JF, Adenis A, Hennequin C, Denis B, Ducreux M.

J Clin Oncol. 2012 Jun 1;30(16):1941-8. doi: 10.1200/JCO.2011.35.4837. Epub 2012 Apr 23. Erratum in: J Clin Oncol. 2012 Nov 1;30(31):3903.

PMID:
22529257
4.

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jitlal M, Ledermann J.

Br J Cancer. 2010 Mar 30;102(7):1123-8. doi: 10.1038/sj.bjc.6605605. Epub 2010 Mar 16.

5.

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C.

JAMA. 2008 Apr 23;299(16):1914-21. doi: 10.1001/jama.299.16.1914.

PMID:
18430910
6.

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR.

Cancer. 2004 Jul 15;101(2):281-8.

7.

Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.

Place RJ, Gregorcyk SG, Huber PJ, Simmang CL.

Dis Colon Rectum. 2001 Apr;44(4):506-12.

PMID:
11330577
8.

Squamous cell carcinoma of the anal canal.

Mitchell SE, Mendenhall WM, Zlotecki RA, Carroll RR.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1007-13.

PMID:
11240241
9.

The Role of Radiation Therapy With 5-Fluorouracil in Anal Cancer.

Cummings BJ.

Semin Radiat Oncol. 1997 Oct;7(4):306-312.

PMID:
10717229
10.

Carcinoma of the anal canal.

Ryan DP, Compton CC, Mayer RJ.

N Engl J Med. 2000 Mar 16;342(11):792-800. Review.

PMID:
10717015
11.

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.

Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R.

Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):127-31.

PMID:
10219805
12.

Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience.

Sandhu AP, Symonds RP, Robertson AG, Reed NS, McNee SG, Paul J.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):575-81.

PMID:
9486607
13.

Anal canal and perianal epidermoid cancers.

Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ.

J Am Coll Surg. 1997 Nov;185(5):494-505. Review. Erratum in: J Am Coll Surg 1998 Jan;186(1):112.

PMID:
9358099
14.

Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.

Peddada AV, Smith DE, Rao AR, Frost DB, Kagan AR.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1101-5.

PMID:
9169819
15.

Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.

John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H, Paris K.

Cancer J Sci Am. 1996 Jul-Aug;2(4):205-11.

PMID:
9166533
17.
18.

Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study.

Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, Oken MM, Haller DG.

Cancer. 1995 Nov 15;76(10):1731-6.

20.

Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.

Longo WE, Vernava AM 3rd, Wade TP, Coplin MA, Virgo KS, Johnson FE.

Ann Surg. 1994 Jul;220(1):40-9.

Supplemental Content

Support Center